Register below for our Innovation Showcase, Focus Session and Panel Discussion

INNOVATION SHOWCASE

Key learnings:
-Impact of deterministic cell programming on reproducibility and scalability of stem cells in research and therapies
-Insights into Alzheimer’s disease pathogenesis, and stem cells for disease modelling and drug development
-The use of deterministically programmed human iPSC-derived cells in CRISPR knockout screens and to study neural networks and their modulation by drugs

FOCUS SESSION

Mark Kotter (bit.bio CEO and founder) will share success stories and retrospective learnings that have helped to overcome hurdles in manufacturing human cells consistently at scale.

Other panellists include: Sandra Milasta, Blue Rock Therapeutics, USA; Wolfram H. Zimmermann, University Medical Center Göttingen (UMG), GER; Christine Günther, Evotec, GER; Lorenz Studer, Memorial Sloan Kettering Cancer Center, USA

PANEL DISCUSSION

A discussion on standard implementation with a broad international forum of researchers featuring Dr. Mark Kotter (bit.bio CEO and founder).

Other panellists include: Christine L. Mummery, Leiden University Medical Center, NLD; Martin F. Pera, The Jackson Laboratories, USA; Glyn Stacey, National Institute for Biological Standards and Control, GBR; Carlos A. Tristan, National Institutes of Health, USA